Respiratory Viral Infection in Exacerbations of COPD

Overview

Journal Respir Med

Publisher Elsevier

Specialty Pulmonary Medicine

Date 2008 Aug 2

PMID 18672353

Citations 79

Authors

Terence E McManus

Anne-Marie Marley

Noreen Baxter

Sharon N Christie

Hugh J ONeill

J Stuart Elborn

Peter V Coyle

Joseph C Kidney

Affiliations

Soon will be listed here.

Abstract

Background: Patients with COPD have frequent exacerbations. The role of respiratory viral infection is just emerging. We wished to determine prospectively the incidence of viral infection in exacerbated and stable COPD patients as well as smokers who do not have airways obstruction.

Methods: Stable and exacerbated COPD patients were recruited along with a group of patients who had smoked but who did not have any airways obstruction. Spirometry was performed and sputum specimens were tested for a range of 12 different respiratory viruses using PCR.

Results: One hundred and thirty-six patients with exacerbations of COPD, 68 stable COPD patients and 16 non-obstructed smokers were recruited. A respiratory virus was detected in 37% of exacerbations, 12% of stable COPD patients and 12% of non-obstructed smokers, p<0.0005. Rhinovirus was most frequently detected. The symptom of fever was associated with virus detection, p<0.05. Infection with more than one virus was only found in the exacerbated COPD patients.

Conclusion: Respiratory viral infection is associated with exacerbations of COPD. Rhinovirus was the most common infecting agent identified and in two cases human metapneumovirus was also detected. Dual infections were only seen amongst those patients admitted to hospital with acute exacerbations of COPD. Viruses were more commonly detected in those with more severe airways disease.

Citing Articles

Clinical Characteristics and Outcomes of Hospitalized AECOPDs Secondary to SARS-CoV-2 versus Other Respiratory Viruses.

Chhor L, Saggese S, Hamilton G, MacDonald M Int J Chron Obstruct Pulmon Dis. 2024; 19:2421-2430.

PMID: 39559372 PMC: 11572465. DOI: 10.2147/COPD.S479968.

Protecting the elderly from influenza in the context of immune system senescence. Elderly aged 65 and over are vulnerable to influenza and its associated complications.: Position paper by the Romanian Society of Gerontology and Geriatrics.

Prada G, Bajenaru O, Chelu G, Matei-Linca C, Nuta C, Moscu S J Med Life. 2024; 17(7):746-754.

PMID: 39440332 PMC: 11493167. DOI: 10.25122/jml-2024-0274.

Genomic Epidemiology and Evolution of Rhinovirus in Western Washington State, 2021-2022.

Goya S, Wendm S, Xie H, Nguyen T, Barnes S, Shankar R J Infect Dis. 2024; 231(1):e154-e164.

PMID: 38963827 PMC: 11793040. DOI: 10.1093/infdis/jiae347.

Respiratory Infection Triggering Severe Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Abi Abdallah G, Diop S, Jamme M, Legriel S, Ferre A Int J Chron Obstruct Pulmon Dis. 2024; 19:555-565.

PMID: 38440747 PMC: 10909653. DOI: 10.2147/COPD.S447162.

RVdb: a comprehensive resource and analysis platform for rhinovirus research.

Zhao P, Zhou S, Xu P, Su H, Han Y, Dong J Nucleic Acids Res. 2023; 52(D1):D770-D776.

PMID: 37930838 PMC: 10768139. DOI: 10.1093/nar/gkad937.

References

Rohde G, Wiethege A, Borg I, Kauth M, Bauer T, Gillissen A . Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003; 58(1):37-42. PMC: 1746460. DOI: 10.1136/thorax.58.1.37. View

Beckham J, Cadena A, Lin J, Piedra P, Glezen W, Greenberg S . Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect. 2005; 50(4):322-30. PMC: 7132437. DOI: 10.1016/j.jinf.2004.07.011. View

Seemungal T, Bhowmik A, Moric I, SANDERSON G, Message S, MacCallum P . Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164(9):1618-23. DOI: 10.1164/ajrccm.164.9.2105011. View

Pauwels R, Buist A, Ma P, Jenkins C, Hurd S . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive.... Respir Care. 2001; 46(8):798-825. View

Seemungal T, Bhowmik A, Jeffries D, Wedzicha J . Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J. 2000; 16(4):677-83. PMC: 7163563. DOI: 10.1034/j.1399-3003.2000.16d19.x. View

Menec V, Black C, MacWilliam L, Aoki F . The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality. Can J Public Health. 2003; 94(1):59-63. PMC: 6979722. View

Brusasco V, Crapo R, Viegi G . Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J. 2005; 26(1):1-2. DOI: 10.1183/09031936.05.00034205. View

Rohde G, Borg I, Arinir U, Kronsbein J, Rausse R, Bauer T . Relevance of human metapneumovirus in exacerbations of COPD. Respir Res. 2005; 6:150. PMC: 1334186. DOI: 10.1186/1465-9921-6-150. View

Walsh E, Falsey A, Hennessey P . Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med. 1999; 160(3):791-5. DOI: 10.1164/ajrccm.160.3.9901004. View

10.

van den Hoogen B, de Jong J, Groen J, Kuiken T, de Groot R, Fouchier R . A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001; 7(6):719-24. PMC: 7095854. DOI: 10.1038/89098. View

11.

MACEK V, Dakhama A, Hogg J, Green F, Rubin B, Hegele R . PCR detection of viral nucleic acid in fatal asthma: is the lower respiratory tract a reservoir for common viruses?. Can Respir J. 1999; 6(1):37-43. DOI: 10.1155/1999/938049. View

12.

Sethi S . Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000; 117(5 Suppl 2):380S-5S. DOI: 10.1378/chest.117.5_suppl_2.380s. View

13.

Greenberg S, Allen M, Wilson J, Atmar R . Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162(1):167-73. DOI: 10.1164/ajrccm.162.1.9911019. View

14.

Stockton J, Stephenson I, Fleming D, Zambon M . Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg Infect Dis. 2002; 8(9):897-901. PMC: 2732534. DOI: 10.3201/eid0809.020084. View

15.

Thompson W, Shay D, Weintraub E, Brammer L, Cox N, Anderson L . Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289(2):179-86. DOI: 10.1001/jama.289.2.179. View

16.

Anthonisen N, Manfreda J, Warren C, Hershfield E, Harding G, Nelson N . Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987; 106(2):196-204. DOI: 10.7326/0003-4819-106-2-196. View

17.

Sethi S . Bacterial infection and the pathogenesis of COPD. Chest. 2000; 117(5 Suppl 1):286S-91S. DOI: 10.1378/chest.117.5_suppl_1.286s. View

18.

Fleming D . The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Commun Dis Public Health. 2000; 3(1):32-8. View

19.

Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies W, Hogg J . Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis. 1992; 146(1):177-84. DOI: 10.1164/ajrccm/146.1.177. View

20.

Bhowmik A, Seemungal T, Sapsford R, Wedzicha J . Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000; 55(2):114-20. PMC: 1745686. DOI: 10.1136/thorax.55.2.114. View